SCHEMBL7047916

SCHEMBL7047916

Cn1c(-c2ccc(CN)cc2)nc2ccccc21

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.69
▸ KDM4E B2RXH2 8/20 0.69
▸ RAB9A P51151 7/20 0.69
▸ NPC1 O15118 6/20 0.69
▸ PKM P14618 4/20 0.69
▸ GAA P10253 4/20 0.69
▸ TP53 P04637 3/20 0.69
▸ HSD17B10 Q99714 2/20 0.69
▸ ALOX15 P16050 1/20 0.69
▸ MEN1 O00255 2/20 0.62
▸ KMT2A Q03164 2/20 0.62
▸ SMN1; SMN2 Q16637 5/20 0.61
▸ MAPT P10636 3/20 0.61
▸ HPGD P15428 3/20 0.61
▸ LMNA P02545 2/20 0.61
▸ HTT P42858 2/20 0.61
▸ GFER P55789 1/20 0.61
▸ CA1 P00915 1/20 0.61
▸ CA2 P00918 1/20 0.61
▸ RXFP1 Q9HBX9 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20982597 0.87 ALDH1A1 (0.83) ALDH1A1KDM4ERAB9ANPC1PKM
SCHEMBL17973875 0.86 ALDH1A1 (0.67) ALDH1A1KDM4ERAB9ANPC1PKM
SCHEMBL10387107 0.84 ALDH1A1 (0.65) ALDH1A1KDM4ERAB9ANPC1PKM
SCHEMBL31474745 0.82 ALDH1A1 (1.00) ALDH1A1KDM4ERAB9ANPC1PKM
SCHEMBL9705114 0.82 ALDH1A1 (1.00) ALDH1A1KDM4ERAB9ANPC1PKM
SCHEMBL28564064 0.82 ALDH1A1 (0.61) ALDH1A1KDM4ERAB9ANPC1PKM
SCHEMBL28560748 0.82 ALDH1A1 (0.61) ALDH1A1KDM4ERAB9ANPC1PKM
SCHEMBL29479576 0.82 ALDH1A1 (0.61) ALDH1A1KDM4ERAB9ANPC1PKM
SCHEMBL29479577 0.82 ALDH1A1 (0.61) ALDH1A1KDM4ERAB9ANPC1PKM
SCHEMBL29479573 0.82 ALDH1A1 (0.61) ALDH1A1KDM4ERAB9ANPC1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1301464-A1 BIPHENYLCARBOXYLIC ACID AMIDES, PRODUCTION THEREOF AND USE THEREOF AS MEDICAMENTS Boehringer Ingelheim Pharma KG (DE) 2003-04-16 — — EP disclosed
US-20020032238-A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-03-14 — — US disclosed
WO-2002004403-A1 BIPHENYLCARBOXYLIC ACID AMIDES, PRODUCTION THEREOF AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-01-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020032238-A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments MTTP, CETP, FABP1 ALDH1A1 190/4885KDM4E 1707/4885RAB9A 4376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback